Primer on Kidney Diseases, Volume 953As an official publication of the National Kidney Foundation (NKF), Primer on Kidney Diseases has received wide critical acclaim since it first published in 1994. Now in its 4th Edition, it continues to provide a current view of the pathophysiology, diagnosis, and management of kidney disease, fluid and electrolyte disorders, hypertension, dialysis, and renal transplantation. · Incorporates the latest NKF Kidney/Outcome Quality Initiative (K/DOQI) guidelines on chronic kidney disease staging and management. · Delivers balanced and accurate cutting-edge management and treatment guidelines. · Features over 70 international experts in all who offer fresh perspectives and a global view of kidney disease. · Presents new chapters on pathogenesis and pathophysiology of diabetic nephropathy and genetic basis of glomerular and structural kidney disorders. . · Provides expanded coverage of the pathophysiology and management of chronic kidney disease. · Includes a more colorful interior design plus redrawn artwork for ease of use. |
Contents
CHAPTER 2 | 2 |
CHAPTER | 6 |
CHAPTER 4 | 17 |
Structure 2 | 19 |
2 | 23 |
Clinical Evaluation of Harold M Szerlip | 74 |
Kidney Function 20 | 84 |
Chiyuan | 90 |
Kidney Disorders Associated with | 273 |
SECTION V | 279 |
Clinical Approach to the Diagnosis | 287 |
Kidney Failure Due to Therapeutic | 293 |
Cholesterol Atheroembolic Kidney | 304 |
Management of Acute Renal | 315 |
SECTION VI | 323 |
Principles of Drug Therapy in Kidney | 331 |
Alkalosis | 97 |
Disorders of Potassium | 110 |
1 | 114 |
Disorders of Calcium and Phosphorus | 120 |
4 | 127 |
Edema and the Clinical Use | 136 |
SECTION III | 149 |
Minimal Change Disease | 165 |
9 | 171 |
Focal Segmental | 178 |
Immunoglobulin A Nephropathy | 191 |
Goodpastures Syndrome and Other | 199 |
SECTION IV | 205 |
Kidney Function in Liver Disease | 213 |
Postinfectious Glomerulonephritis | 219 |
6 | 226 |
Kidney Manifestations of Systemic | 234 |
Pathogenesis and Pathophysiology | 241 |
9 | 247 |
Dysproteinemias | 256 |
Thrombotic Microangiopathies | 265 |
SECTION VII | 337 |
Genetic Basis of Renal Transport | 344 |
Sickle Cell Nephropathy | 351 |
6 | 357 |
Alports Syndrome and Related | 363 |
SECTION VIII | 373 |
LithiumInduced Kidney Disease | 382 |
Obstructive Uropathy | 389 |
Vesicoureteral Reflux and Reflux | 399 |
Urinary Tract Infection | 411 |
SECTION IX | 419 |
The Kidney in Pregnancy | 426 |
The Kidney in Aging | 436 |
SECTION X | 443 |
Staging | 455 |
Hemodialysis and Hemofiltration | 464 |
Management | 495 |
Hypertension 555 Hypertension 555 | 502 |
5 | 564 |
6 Secondary Hypertension 573 Colin Mason and Peter J Conlon | 585 |
Other editions - View all
Common terms and phrases
abnormal acid acid-base acidosis activity acute addition administration agents aldosterone alkalosis anions appear arterial associated bicarbonate biopsy blood body calcium capillary cause cells changes chronic clinical collecting common complex concentration creatinine decrease deposits detected develop diabetic diagnosis disease disorders distal diuretics dose drugs effects evaluation excretion extracellular factors failure fluid frequently glomerular glomerulonephritis glucose greater HCO3 hematuria hypertension hypokalemia hyponatremia impaired important increase indicate infection initial kidney disease kidney function lead lesions less levels light loop loss lupus magnesium measured mechanisms membrane metabolic nephritis nephropathy nephrotic normal occurs patients phosphorus plasma potassium present pressure primary produce progressive protein proteinuria proximal reabsorption reduced renal respiratory response retention risk secondary secretion segmental serum severe sodium solute specific stimulates studies suggests syndrome Table therapy tion treated treatment tubular tubule urinary urine usually volume